Celanese Corp Stock: price and insider trades · United States · SEC (Form 4)Track the Celanese Corp share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Chemicals & Materials sector, Celanese Corp has published 186 reports. Market capitalisation: €5bn. The latest transaction was reported on 17 August 2026 (Acquisition). Among the most active insiders: Murray Mark Christopher. All data is free.
Analyst consensus: bullish or bearish? Analysts rate Celanese Corp Buy (bullish), based on 16 analysts. Average price target: US$63.63.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,228 of 29,062 companies
FCF yld 16%
Earn yld -23%
EV/EBITDA ·
ROE -22%
Gross mgn 20%
Net mgn -12%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
All Executives186 Thresholds0 Prospectus0 Other0
Declarations 186 total
▲ SVP & CFO · Executives · 14 Aug 2026
1,400 shares @ US$45.5299 Common Stock SEC:0002000660-26-000004:0
Canonical exit: 12 Nov 2026 (T+90) ▲ SVP & CFO · Executives · 14 Aug 2026
100 shares @ US$45.505 Common Stock SEC:0002000660-26-000004:1
Canonical exit: 12 Nov 2026 (T+90) ▲ SVP & CFO · Executives · 14 Aug 2026
800 shares @ US$45.5072 Common Stock SEC:0002000660-26-000004:2
Canonical exit: 12 Nov 2026 (T+90) ▲ SVP & GC · Executives · 11 Aug 2026
600 shares @ US$45.60 0.0006% mcap 100.0% of flow Common Stock SEC:0002000487-26-000003:0
Canonical exit: 9 Nov 2026 (T+90) ◆ Director · Executives · 10 Aug 2026
1,930 shares 0Common Stock SEC:0001199009-26-000006:0
▲ SVP - Acetyls · Executives · 11 Aug 2026
2,153 shares @ US$45.5199 0.0020% mcap 10.3% of flow Common Stock SEC:0001800013-26-000003:0
Canonical exit: 9 Nov 2026 (T+90) ◆ Director · Executives · 11 May 2026
2,975 shares 0Common Stock SEC:0001218184-26-000003:0
◆ CEO & President · Executives · 27 Feb 2026
50,623 shares 0Common Stock SEC:0001306830-26-000044:0
◆ SVP - Acetyls · Executives · 27 Feb 2026
10,431 shares 0Common Stock SEC:0001306830-26-000043:0
◆ Chief Accounting Officer · Executives · 27 Feb 2026
1,687 shares 0Common Stock SEC:0001306830-26-000042:0
◆ SVP, EM · Executives · 27 Feb 2026
12,579 shares 0Common Stock SEC:0001306830-26-000040:0
◆ SVP & GC · Executives · 27 Feb 2026
10,431 shares 0Common Stock SEC:0001306830-26-000039:0
◆ SVP & CFO · Executives · 27 Feb 2026
15,678 shares 0Common Stock SEC:0001306830-26-000041:0
◆ CEO & President · Executives · 15 Feb 2026
3,336 shares 0Common Stock SEC:0001306830-26-000027:0
◆ SVP - Acetyls · Executives · 15 Feb 2026
1,205 shares 0Common Stock SEC:0001306830-26-000026:0
◆ Chief Accounting Officer · Executives · 15 Feb 2026
173 shares 0Common Stock SEC:0001306830-26-000025:0
◆ SVP & CFO · Executives · 15 Feb 2026
401 shares 0Common Stock SEC:0001306830-26-000024:0
◆ SVP & GC · Executives · 15 Feb 2026
618 shares 0Common Stock SEC:0001306830-26-000023:0
● Director · Executives · 1 Jan 2026
1,808.351 shares 0Common Stock SEC:0001306830-26-000005:0
▲ CEO & President · Executives · 10 Dec 2025
3,800 shares @ US$41.5899 7.3% of flow Common Stock SEC:0001306830-25-000245:0
Canonical exit: 10 Mar 2026 (T+90) ▲ SVP & CFO · Executives · 9 Dec 2025
5,000 shares @ US$41.03 100.0% of flow Common Stock SEC:0001306830-25-000243:0
Canonical exit: 9 Mar 2026 (T+90) ◆ Chief Accounting Officer · Executives · 17 Nov 2025
2,980 shares 0Common Stock SEC:0001306830-25-000241:0
◆ SVP & GC · Executives · 17 Nov 2025
6,624 shares 0Common Stock SEC:0001306830-25-000240:0
▲ Director · Executives · 8 Sept 2025
500 shares @ US$46.33 10.9% of flow Common Stock SEC:0001306830-25-000200:0
Canonical exit: 7 Dec 2025 (T+90) ▲ SVP - Acetyls · Executives · 14 Aug 2025
2,017 shares @ US$41.83 10.8% of flow Common Stock SEC:0001306830-25-000198:0
Canonical exit: 12 Nov 2025 (T+90) 25 of 186 declarations
Load more (161 remaining) 关于 Celanese Corp Celanese Corp.(股票代码:CE)是一家在美国纽约证券交易所上市的美国公司。它是一家全球性的特种化学品和先进材料集团,具有清晰的工业特征:该公司配制、制造和商业化用于广泛终端市场的差异化化学解决方案。对于法国、比利时和瑞士的投资者而言,Celanese最好被视为一家周期性但具有附加值的材料业务,其收益受工业需求、投入成本动态以及公司维持定价和管理价差的能力驱动。
Celanese的历史可以追溯到1918年,当时最初的业务在纤维素化学的早期时代成立。现代的Celanese公司于2004年重组,如今其全球总部位于德克萨斯州达拉斯地区的欧文市。该公司还强调其国际运营足迹,在北美、欧洲和亚太地区拥有制造、商业和技术能力。这种地理覆盖范围很重要,因为Celanese销售到多元化的工业供应链,并服务于需要本地支持、应用开发和可靠全球供应的客户。
该业务围绕两个核心支柱组织:工程材料和乙酰链。工程材料涵盖用于汽车、电子、医疗设备、工业组件和消费品等严苛应用的高性能聚合物解决方案。主要产品系列包括缩醛共聚物(POM)、聚对苯二甲酸丁二醇酯(PBT)、液晶聚合物(LCP)、热塑性硫化橡胶(TPV)、尼龙和其他特种热塑性塑料。当客户需要轻量化、精密性、耐热性、耐化学性或耐用机械性能时,通常会选择这些材料。
乙酰链是Celanese的集成乙酰平台,以乙酸、乙酸酐和醋酸乙烯单体(VAM)等中间体为中心。这些产品广泛应用于粘合剂、涂料、工业化学品、消费品应用和其他特种价值链。该部门为Celanese带来了规模、整合和运营杠杆,同时也使公司面临类似大宗商品的定价波动和供需周期。
在竞争方面,Celanese在大宗化学品和纯特种材料之间占据了一个有吸引力的利基市场。公司的优势在于其技术诀窍、应用工程、客户亲密度以及产品组合的广度。这种组合支持与工业客户的经常性关系,并帮助Celanese在整个周期中保持利润,尽管业绩仍然受原材料成本、工厂利用率和终端市场条件的影响。
投资者应注意的近期事项包括持续的SEC Form 4内部人活动。最新的内部人文件显示,多项股权奖励授予高管和董事,以及高级领导层在2025年末和2026年初进行的精选内部人购买。从分析角度来看,这些文件值得关注,因为它们可以提供管理层信心和长期一致性的信号。Celanese还继续强调两个业务部门的投资组合优化、运营纪律和可持续产品计划。